Anzeige
Mehr »
Samstag, 27.06.2026 - Börsentäglich über 12.000 News
Brasiliens Moment für seltene Erden ist gekommen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40VM0 | ISIN: US8902608392 | Ticker-Symbol: TPM0
Tradegate
26.06.26 | 21:50
11,285 Euro
-2,42 % -0,280
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TONIX PHARMACEUTICALS HOLDING CORP Chart 1 Jahr
5-Tage-Chart
TONIX PHARMACEUTICALS HOLDING CORP 5-Tage-Chart
RealtimeGeldBriefZeit
11,60011,62513:04
11,39511,74026.06.

Aktuelle News zur TONIX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
TONIX PHARMACEUTICALS Aktie jetzt für 0€ handeln
DoTonix, MapLight are new Strong Buys at Raymond James on upcoming catalysts2
DoThis Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday2
MiRaymond James initiates Tonix Pharma stock coverage with strong buy1
11.06.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 202620
08.06.Tonix-Aktie im Aufwind: Versicherungsabdeckung für Fibromyalgie-Medikament TONMYA erweitert10
08.06.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA, Expanding Total Commercial Coverage to ~52 Million U.S. Lives553Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional U.S. commercial lives (10% of the ~177 million commercial...
► Artikel lesen
08.06.Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report1
28.05.Tonix Pharmaceuticals legt Daten zur Opioid-Nutzung bei Fibromyalgie vor5
28.05.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting1
27.05.Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report3
26.05.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 ...666Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data...
► Artikel lesen
14.05.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 202613
11.05.Tonix Pharmaceuticals GAAP EPS of -$2.93 misses by $0.83, revenue of $6.9M misses by $0.05M5
11.05.Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights2.241In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA, 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading...
► Artikel lesen
11.05.Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report-
11.05.Tonix Pharmaceuticals Holding Corp. - 10-Q, Quarterly Report-
06.05.Tonix Pharmaceuticals: Aktie legt nach Vereinbarung mit Einkaufsgemeinschaft zu9
06.05.Tonix rises on commercial payer coverage for pain therapy2
06.05.Tonix sichert wichtige GPO-Vereinbarung für Fibromyalgie-Medikament TONMYA4
06.05.Tonix secures GPO coverage for fibromyalgia drug TONMYA2
Weiter >>
77 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2